BeStock  
Stocks › DNLI

Denali Therapeutics DNLI

US equityMarket cap rank #2435Biotechnology
$19.91 −$0.09 (-0.45%)
Pre-market · Oct 6, 8:20 am ET · After hours $19.91 0.00%
Open$20.09
Prev close$20.00
Day range$19.54 – $20.09
Volume1.72M
Market cap$3.18B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts13
Average target$35.09+76.2% vs. price
  • Buy 100%
Low $26.00Now $19.91Avg $35.09High $42.00

Recent rating changes

The last 20 actions on file set price targets from $25.00 to $42.00, averaging $34.78.

DateFirmRatingTarget
25 Aug 2026 B. Riley Securities BUY $35.00
11 Aug 2026 J.P. Morgan BUY $29.00
7 Aug 2026 William Blair BUY –
7 Aug 2026 UBS BUY $34.00
7 Aug 2026 BofA Securities BUY $31.00
7 Aug 2026 Baird BUY $34.00
7 Aug 2026 Morgan Stanley BUY $40.00
7 Aug 2026 Stifel BUY $41.00
7 Aug 2026 H.C. Wainwright BUY $42.00
6 Aug 2026 TD Cowen BUY –
6 Aug 2026 BTIG BUY $39.00
23 Jul 2026 Morgan Stanley BUY $36.00
16 Jul 2026 Deutsche Bank BUY $35.00
15 Jul 2026 BofA Securities BUY $31.00
13 Jul 2026 Wedbush BUY $26.00
13 Jul 2026 H.C. Wainwright BUY $42.00
13 Jul 2026 J.P. Morgan BUY $29.00
8 Jul 2026 H.C. Wainwright BUY $42.00
16 Jun 2026 UBS BUY $25.00
26 May 2026 Morgan Stanley BUY $35.00

Discussion

No comments yet — be the first to weigh in on DNLI.

Leave a comment

Scroll to Top